Title : Use of cystatin C to inform metformin eligibility among adult veterans with diabetes.

Pub. Date : 2016 Mar

PMID : 28603691






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIMS: Recommendations for metformin use are dependent on eGFR category: eGFR >45 ml/min/1.73 m2 - "first-line agent"; eGFR 30-44 - "use with caution"; eGFR<30 - "do not use". Metformin epidermal growth factor receptor Homo sapiens
2 AIMS: Recommendations for metformin use are dependent on eGFR category: eGFR >45 ml/min/1.73 m2 - "first-line agent"; eGFR 30-44 - "use with caution"; eGFR<30 - "do not use". Metformin epidermal growth factor receptor Homo sapiens
3 AIMS: Recommendations for metformin use are dependent on eGFR category: eGFR >45 ml/min/1.73 m2 - "first-line agent"; eGFR 30-44 - "use with caution"; eGFR<30 - "do not use". Metformin epidermal growth factor receptor Homo sapiens
4 AIMS: Recommendations for metformin use are dependent on eGFR category: eGFR >45 ml/min/1.73 m2 - "first-line agent"; eGFR 30-44 - "use with caution"; eGFR<30 - "do not use". Metformin epidermal growth factor receptor Homo sapiens
5 METHODS: In a consecutive cohort of 550 Veterans with diabetes, metformin use and eligibility were assessed by eGFR category, using eGFRcr and eGFRcys. Metformin epidermal growth factor receptor Homo sapiens
6 Metformin use decreased with severity of eGFRcr category, from 63% in eGFRcr >60 to 3% in eGFRcr <30. eGFRcys reclassified 20% of Veterans into different eGFR categories. Metformin epidermal growth factor receptor Homo sapiens